- Home
- MLAB vs IGR Comparison
MLAB vs IGR Comparison
Compare MLAB & IGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- IGR
- Stock Information
- Founded
- MLAB 1982
- IGR 2004
- Country
- MLAB United States
- IGR United States
- Employees
- MLAB N/A
- IGR N/A
- Industry
- MLAB Industrial Machinery/Components
- IGR Finance Companies
- Sector
- MLAB Industrials
- IGR Finance
- Exchange
- MLAB Nasdaq
- IGR Nasdaq
- Market Cap
- MLAB 692.9M
- IGR 691.7M
- IPO Year
- MLAB N/A
- IGR N/A
- Fundamental
- Price
- MLAB $139.61
- IGR $5.27
- Analyst Decision
- MLAB Hold
- IGR
- Analyst Count
- MLAB 2
- IGR 0
- Target Price
- MLAB $140.00
- IGR N/A
- AVG Volume (30 Days)
- MLAB 38.7K
- IGR 747.7K
- Earning Date
- MLAB 02-03-2025
- IGR 01-01-0001
- Dividend Yield
- MLAB 0.46%
- IGR 13.93%
- EPS Growth
- MLAB N/A
- IGR N/A
- EPS
- MLAB N/A
- IGR N/A
- Revenue
- MLAB $228,380,000.00
- IGR N/A
- Revenue This Year
- MLAB $11.32
- IGR N/A
- Revenue Next Year
- MLAB $5.98
- IGR N/A
- P/E Ratio
- MLAB N/A
- IGR N/A
- Revenue Growth
- MLAB 6.88
- IGR N/A
- 52 Week Low
- MLAB $83.68
- IGR $3.88
- 52 Week High
- MLAB $147.34
- IGR $5.70
- Technical
- Relative Strength Index (RSI)
- MLAB 58.92
- IGR 57.60
- Support Level
- MLAB $131.90
- IGR $4.76
- Resistance Level
- MLAB $147.34
- IGR $4.94
- Average True Range (ATR)
- MLAB 5.52
- IGR 0.12
- MACD
- MLAB -0.41
- IGR 0.07
- Stochastic Oscillator
- MLAB 64.28
- IGR 96.23
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.